watsa_is_a_randian_hero Posted October 4, 2011 Share Posted October 4, 2011 Anyone have insight as to recent significant decline? Company has declined much more than other pharma over the recent bear market. The company is leveraged - did a levered dividend last year. On a EV/EBITDA sell at a 5-6x multiple - similar to some other pharma. However, because of cheap leverage it is selling at a PE of 3x. Debt/EBITDA is about 2.0-2.5x. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now